Children are among the most vulnerable groups in society and need special care. Bronchial asthma is a common non-communicable disease that affects both children and adults. It is the most frequent chronic illness in children. Asthma is marked by episodes of breathing difficulty caused by airway inflammation and blockage, which is usually reversible.

Out of 200 million asthma patients worldwide, about 15 million are in India. In Indian children aged 5–11 years, the estimated asthma rate is 10% to 15%. Moderate to severe cases need daily treatment with long-term medicines (like anti-inflammatory drugs) to manage inflammation and prevent symptoms. Inhaled short-acting medicines are used to relieve sudden symptoms.

A major breakthrough in modern treatment is inhalation therapy, using drugs like Salbutamol and corticosteroids via nebulizers or aerosols. Inhaled medicine works fast because the lungs absorb it quickly, providing quick relief.

However, modern medicines often cause side effects and may not be ideal for long-term use. In Ayurveda, Bronchial Asthma is similar to "Tamaka Shwasa," a Vata-Kaphaja disorder with symptoms like labored breathing, cough, and wheezing. Herbal treatments (phyto-medicines) are becoming popular again due to their safety and effectiveness, as shown in clinical studies.

There is a need to develop Ayurvedic inhalation therapies that are safe, effective, and suitable for daily use. Herbs with properties like pungent (Katu), bitter (Tikta) taste, hot potency (Ushna Virya), and volatile nature are useful for nebulization. Dronapushpi and Parnayavani have these qualities. They help clear airways by reducing Kapha and supporting Vata balance.

Studies show these herbs contain volatile oils with strong bronchodilator effects. Using them as a distillate (Arka) in nebulization may benefit children with Tamaka Shwasa. This study focuses on evaluating the effectiveness of Dronapushpi Arka nebulization in such cases.